Skip to main content
Clinical Trials/JPRN-jRCT1021210071
JPRN-jRCT1021210071
Recruiting
未知

An exploratory study of the relationship between dementia indicators and frontal EEG in normal subjects and patients with Alzheimer's disease

Takanami Kentaro0 sites95 target enrollmentMarch 2, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Alzheimer's disease
Sponsor
Takanami Kentaro
Enrollment
95
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Takanami Kentaro

Eligibility Criteria

Inclusion Criteria

  • (1\) Those who are between 45 and 80 years old at the time of obtaining consent.
  • (2\) Those who have received sufficient explanation and understanding of this research, and who have given their free and voluntary consent in writing.
  • (1\) Patients who are between 45 and 80 years of age at the time of consent.
  • (2\) Patients who have been diagnosed with probable Alzheimer's disease (AD) according to the NIA\-AA diagnostic criteria1\).
  • (3\) Those who have received sufficient explanation and understanding of this research and who have given their free and voluntary consent in writing. (4\) A person who has been fully informed about this research and understands it, and who has given written consent of his/her own free will. Or, if the person lacks sufficient capacity to give consent, a person who has given written consent from a substitute.

Exclusion Criteria

  • Healthy subjects
  • Those with a history of or complications from neurological diseases
  • Those who have performed MMSE or MoCAJ within 6 months
  • Those with mental illness
  • Those who are taking medication that may affect EEG measurement
  • Those with severe complications (malignant tumor, myocardial infarction, heart failure, etc.) that may affect the amyloid beta PET CT test and EEG measurement
  • Those whose physician judges that it is difficult to perform amyloid beta PET CT test due to some physical conditions (e.g., allergy to flutemetamol (18F))
  • Those who, for some reason (frontal trauma, frontal skin disease, skull defect, blindness, etc.), are considered to have difficulty in performing EEG measurement and tasks during EEG measurement
  • Pregnant women, nursing mothers, and those who wish to become pregnant during the research period
  • Those who are participating in other research.

Outcomes

Primary Outcomes

Not specified

Similar Trials